Interleukin-10 modulates susceptibility in experimental cerebral malaria

Immunology

Volumn 91, Issue 4, 1997, Pages 536-540

  Kossodo, S ^a,d   Monso, C ^a   Juillard, P ^a   Velu, T ^b   Goldman, M ^c   Grau, G E ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d Hopital Cantonal   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; HOST RESISTANCE; IMMUNOMODULATION; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL;

EID: 0030841167     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00290.x     Document Type: Article

References (31)

1. GRAU G.E., FAARDO L.F., PIGUET P.F., ALLET B., LAMBERT P.H. & VASSALLI P. (1987) Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237, 1210.
2. GRAU G.E., PIGUET P.F., VASSALLI P. & LAMBERT P.H. (1989) Tumor necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev 112, 49.
3. DE KOSSODO S. & GRAU G.E. (1993) Profiles of cytokine production in relation with susceptibility to experimental cerebral malaria. J Immunol 151, 4811.
4. GRAU G.E., HEREMANS H., PIGUET P.F. et al. (1989) Monoclonal antibody against interferon-gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci USA 86, 5572.
5. KERN P., HEMMER C.J., VANDAMME J., GRUSS H.J. & DIETRICH M. (1989) Elevated tumor necrosis factor-alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med 87, 139.
6. GRAU G.E., TAYLOR T.E., MOLYNEUX M.E. et al. (1989) Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320, 1586.
7. KWIATKOWSKI D., HILL A.V., SAMBOU I. et al. (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336, 1201.
8. FIORENTINO D.F., BOND M.W. & MOSMANN T.R. (1989) 2 Types of mouse T-helper cell Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170, 2081.
9. MOORE K.W., VIEIRA P., FIORENTINO D.F., TROUNSTINE M.L., KHAN T.A. & MOSMANN T.R. (1990) Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene Bcrfi. Science 248, 1230.
10. FIORENTINO D.F., ZLOTNIK A., MOSMANN T.R., HOWARD M. & OGARRA A. (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147, 3815.
11. FIORENTINO D.F., ZLOTNIK A., VIEIRA P., et al. (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146, 3444.
12. PEYRON F., BURDIN N., RINGWALD P., VUILLEZ J.P., ROUSSET F. & BANCHEREAU J. (1990) High levels of circulating IL-10 in human malaria. Clin Exp Immunol 95, 300.
13. WENISCH C., PARSCHALK B., NARZT E., LOOAREESUWAN S. & GRANINGER W. (1995) Elevated serum levels of IL-10 and IFN-gamma in patients with acute Plasmodium falciparum malaria. Clin Immunol Immunopathol 74, 115.
14. ECKWALANGA M., MARUSSIG M., TAVARIS M.D. et al. (1994) Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4 (+) cell-mediated pathology. Proc Natl Acad Sci USA 91, 8097.
15. + T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J Immunol 137, 2348.
16. GERARD C., BRUYNS C., MARCHANT A. et al. (1993) Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177, 547.
17. CHOMCZYNSKI P. & SACCHI N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156.
18. SLADE S.J. & LANGHORNE J. (1989) Production of interferon-gamma during infection of mice with Plasmodium chabaudi-chabaudi. Immunobiology 179, 353.
19. DUREZ P., ABRAMOWICZ D., GERARD C. et al. (1993) In vivo Induction of interleukin-10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide - differential modulation by cyclosporin-A.J Exp Med 177, 551.
20. GARCIA I., ARAKI K., MIYAZAKI Y. et al. (1995) Transgenic mice expressing soluble TNF-R1-IgG3 molecules are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections Eur J Immunol 25, 2401.
21. WILLEMS F., MARCHANT A., DELVILLE J.P. et al. (1994) Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 24, 1007.
22. GAZZINELLI R.T., ELTOUM I., WYNN T.A. & SHER A. (1993) Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J Immunol 151, 3672.
23. HUNTER C.A., LITTON M.J., REMINGTON J.S. & ABRAMS J.S. (1994) Immunocytochemical detection of cytokines in the lymph nodes and brains of mice resistant or susceptible to toxoplasmic encephalitis. J Infect Dis 170, 939.
24. + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J Immunol 798.
25. SUZUKI Y., ORELLANA M.A., SCHREIBER R.D. & REMINGTON J.S. (1988) Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240, 516.
26. JOHNSON L.L. (1992) A protective role for endogenous tumor necrosis factor in Toxoplasma-gondii infection. Infect Immun 60 (1979).
27. CLARK I.A., HUNT N.H., BUTCHER G.A. & COWDEN W.B. (1987) Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J Immunol 139, 3493.
28. MINOPRIO P., ELCHEIKH M.C., MURPHY E. et al. (1993) Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent. J Immunol 151, 4200.
29. GRAU G.E. & MODLIN R.L. (1991) Immune mechanisms in bacterial and parasitic diseases -protective immunity vs. pathology. Curr Opin Immunol 3, 480.
30. VORA M., YSSEL H., DEVRIES J.E. & KARASEK M.A. (1994) Antigen presentation by human dermal microvascular endothelial cells - immunoregulatory effect of IFN-gamma and 11-10. J Immunol 152, 5734.
31. GRAU G.E., TACCHINI-COTTIER F., VESIN C. et al. (1993) TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction. Eur Cytokine Network 4, 415.